ATE2965T1 - Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern. - Google Patents

Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.

Info

Publication number
ATE2965T1
ATE2965T1 AT80300077T AT80300077T ATE2965T1 AT E2965 T1 ATE2965 T1 AT E2965T1 AT 80300077 T AT80300077 T AT 80300077T AT 80300077 T AT80300077 T AT 80300077T AT E2965 T1 ATE2965 T1 AT E2965T1
Authority
AT
Austria
Prior art keywords
production
methods
antibodies
cell lines
immunogen
Prior art date
Application number
AT80300077T
Other languages
German (de)
English (en)
Inventor
Giovanni Galfre
Cesar Milstein
Bruce William Wright
Original Assignee
National Research Development Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corporation filed Critical National Research Development Corporation
Application granted granted Critical
Publication of ATE2965T1 publication Critical patent/ATE2965T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Semiconductor Memories (AREA)
  • Static Random-Access Memory (AREA)
AT80300077T 1979-01-09 1980-01-08 Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern. ATE2965T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7900775 1979-01-09
EP80300077A EP0014519B1 (en) 1979-01-09 1980-01-08 Cell lines, process for preparing them and process for producing antibodies

Publications (1)

Publication Number Publication Date
ATE2965T1 true ATE2965T1 (de) 1983-04-15

Family

ID=10502406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300077T ATE2965T1 (de) 1979-01-09 1980-01-08 Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.

Country Status (11)

Country Link
US (1) US4350683A (forum.php)
EP (1) EP0014519B1 (forum.php)
JP (3) JPS55113722A (forum.php)
AT (1) ATE2965T1 (forum.php)
AU (1) AU542303B2 (forum.php)
CA (1) CA1142466A (forum.php)
DE (1) DE3062558D1 (forum.php)
DK (1) DK169586B1 (forum.php)
GB (1) GB2039948B (forum.php)
IE (1) IE50418B1 (forum.php)
ZA (1) ZA797020B (forum.php)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043718B1 (en) * 1980-07-07 1984-11-28 National Research Development Corporation Improvements in or relating to cell lines
WO1982000364A1 (en) * 1980-07-16 1982-02-04 Jefferis R Methods of immuno-analysis using monoclonal antibodies
IL62965A0 (en) * 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4722896A (en) * 1981-01-26 1988-02-02 The Beth Israel Hospital Association Method for affinity purification of hybridoma antibodies
JPS58500366A (ja) * 1981-03-06 1983-03-10 セルテツク　リミテツド 単一クロ−ン抗体
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
US4950598A (en) * 1982-09-22 1990-08-21 The Board Of Trustees Of The Leland Stanford Junior University Process for making T cell hybridomas
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
US4508643A (en) * 1983-02-08 1985-04-02 Baxter Travenol Laboratories, Inc. Rat antibody to hCG
GB8318575D0 (en) * 1983-07-08 1983-08-10 Cobbold S P Antibody preparations
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
US4469630A (en) * 1983-11-25 1984-09-04 J. T. Baker Chemical Co. Purification of monoclonal antibodies
US4596769A (en) * 1984-03-05 1986-06-24 Temple University Monoclonal antibodies to peptidoglycan and methods of preparing same
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
JPS60258128A (ja) * 1984-06-06 1985-12-20 Kyowa Hakko Kogyo Co Ltd ラツトモノクロ−ナル抗体
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US4757018A (en) * 1985-02-11 1988-07-12 Hazleton Biotechnologies, Inc. Myeloma cell lines and uses thereof
US4814275A (en) * 1985-05-13 1989-03-21 E.I. Dupont De Nemours And Company Monoclonal hybridoma antibody specific for a human epithelial antigen
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
US5292636A (en) * 1986-03-31 1994-03-08 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
EP0318487B1 (en) * 1986-08-04 1993-10-13 The University Of New South Wales Serum free tissue culture medium containing polymeric cell-protective agent
WO1994022915A1 (en) * 1993-03-31 1994-10-13 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
PT1176195E (pt) * 1999-04-09 2013-07-18 Kyowa Hakko Kirin Co Ltd Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
US7504256B1 (en) * 1999-10-19 2009-03-17 Kyowa Hakko Kogyo Co., Ltd. Process for producing polypeptide
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
AU2003236017B2 (en) 2002-04-09 2009-03-26 Kyowa Kirin Co., Ltd. Drug containing antibody composition
US7340957B2 (en) 2004-07-29 2008-03-11 Los Alamos National Security, Llc Ultrasonic analyte concentration and application in flow cytometry
EA200700433A1 (ru) 2004-09-10 2007-10-26 Корнелл Рисерч Фаундейшн, Инк. Производные бетулинола в качестве агентов против вич (вируса иммунодефицита человека)
CN101193905B (zh) 2005-02-11 2014-06-25 纪念斯隆-凯特林癌症中心 用于检测抗药egfr突变体的方法和组合物
US7835000B2 (en) 2006-11-03 2010-11-16 Los Alamos National Security, Llc System and method for measuring particles in a sample stream of a flow cytometer or the like
WO2008122051A1 (en) 2007-04-02 2008-10-09 Acoustic Cytometry Systems, Inc. Methods and devices for enhanced analysis of field focused cells and particles
US7837040B2 (en) * 2007-04-09 2010-11-23 Los Alamos National Security, Llc Acoustic concentration of particles in fluid flow
US8083068B2 (en) 2007-04-09 2011-12-27 Los Alamos National Security, Llc Apparatus for separating particles utilizing engineered acoustic contrast capture particles
US8528406B2 (en) 2007-10-24 2013-09-10 Los Alamos National Security, LLP Method for non-contact particle manipulation and control of particle spacing along an axis
US8263407B2 (en) 2007-10-24 2012-09-11 Los Alamos National Security, Llc Method for non-contact particle manipulation and control of particle spacing along an axis
US8266951B2 (en) 2007-12-19 2012-09-18 Los Alamos National Security, Llc Particle analysis in an acoustic cytometer
US8714014B2 (en) 2008-01-16 2014-05-06 Life Technologies Corporation System and method for acoustic focusing hardware and implementations
US11324222B2 (en) 2016-03-28 2022-05-10 Toyo Seikan Group Holdings, Ltd. Dispersion liquid, method for producing the same, and copper compound particles
JP6984122B2 (ja) * 2016-12-15 2021-12-17 東洋製罐グループホールディングス株式会社 抗ウイルス性を有する分散液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
FI64952C (fi) * 1977-06-15 1984-02-10 Wistar Inst Foerfarande foer framstaellning av genetiskt stabila cellinjer
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies

Also Published As

Publication number Publication date
GB2039948A (en) 1980-08-20
EP0014519A3 (en) 1981-01-07
US4350683A (en) 1982-09-21
EP0014519A2 (en) 1980-08-20
ZA797020B (en) 1981-08-26
JP2648419B2 (ja) 1997-08-27
IE50418B1 (en) 1986-04-16
JPH02227096A (ja) 1990-09-10
DK169586B1 (da) 1994-12-12
JPS55113722A (en) 1980-09-02
EP0014519B1 (en) 1983-04-06
DK7380A (da) 1980-07-10
DE3062558D1 (en) 1983-05-11
GB2039948B (en) 1983-04-07
JPH052318B2 (forum.php) 1993-01-12
IE800032L (en) 1980-07-09
JPH05276983A (ja) 1993-10-26
AU542303B2 (en) 1985-02-14
JPH032515B2 (forum.php) 1991-01-16
AU5445680A (en) 1980-07-17
CA1142466A (en) 1983-03-08

Similar Documents

Publication Publication Date Title
ATE2965T1 (de) Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.
DE3580654D1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
DE3065072D1 (en) Process for producing antibodies to hepatitis virus and cell lines therefor
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
HK52589A (en) Process for the production of human mono-clonal antibodies
ATE13317T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
ATE14023T1 (de) Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen.
ATA208987A (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
ATE14454T1 (de) Monoklonaler antikoerper gegen menschliche helfer- t-zellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, seine diagnostischen und therapeutischen verwendungen und diesen antikoerper enthaltende diagnostische und therapeutische zusammensetzungen.
DE3583150D1 (de) Festelektrolytbrennstoffzelle und verfahren zu ihrer herstellung.
EP0176355A3 (en) Antigen-independent immunoassay system
AT368656B (de) Optisch auslesbarer scheibenfoermiger aufzeichnungstraeger, verfahren zu dessen herstellung und vorrichtung zur durchfuehrung dieses verfahrens
PT71814B (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and supressor t cells antibody and methods
ES497424A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
ATE12660T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches thymozytantigen, antikoerper und verfahren zu seiner herstellung, diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
DE3485128D1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
NO771104L (no) Fremgangsm}te for dyrkning av celler.
ATA168387A (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
FI820200A7 (fi) Menetelmä vasta-ainetta tuottavien hybridisolujen ja vasta- aineiden valmistamiseksi, hybridisoluja ja vavasta-aineita.
AU560262B2 (en) Antibodies derived from hybrid line from (myeloma + antibody producing cell)
DD135014A1 (de) Solarzellenanordnung und verfahren zu ihrer herstellung
HRP940808B1 (en) Hybrid cell line for producing monoclonal antibody to helper t cells, antibody and method of preparation thereof
HRP940786B1 (en) Hybrid cell line for production of monoclonal antibody for human cytotoxic and supressor t cells, antibody and process
DE3775915D1 (de) Brennstoffzelle mit festelektrolyt und verfahren zu ihrer herstellung.
HRP940822B1 (en) Hybrid cell line for producing complement-fixing monoclonal antibody to human supressor t cells, antibody and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time